SMD Rise, or SMD100, has joined the Stock Exchange of Thailand's JUMP+ program to enhance business potential and governance, setting a revenue growth target of 20 to 30 percent for 2026 from the previous year's revenue of approximately 922 million baht, and aiming to push net profit to 80 to 120 million baht by 2028. The company plans to increase the revenue share from sleep medicine and medical technology businesses, building a comprehensive healthcare ecosystem covering diagnosis through to services and solutions for hospitals and healthcare facilities. In addition, the company emphasizes governance enhancement through anti-corruption measures, a whistleblower system, and prevention of insider information use, which are part of the JUMP+ program that helps increase transparency and investor confidence.
SMD100_SAINTMEDCompany joins JUMP+ program to enhance governance and sets ambitious profit target of 80-120 million baht by 2028.